Financial statements A-Farmacja
Balance sheet data of A-FARMACJA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 14 432 138,69 | 7 841 356,07 | 5 017 667,77 | 5 014 180,21 | 5 014 180,21 |
| A. Fixed assets | 5 436 404,62 | 5 006 623,83 | 5 017 667,77 | 5 014 180,21 | 5 014 180,21 |
| B. Current assets | 8 995 734,07 | 2 834 732,24 | 2 817 017,08 | 2 793 909,32 | 2 792 392,65 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 14 432 138,69 | 7 841 358,07 | 1 557 311,27 | 7 808 089,53 | 7 806 572,86 |
| A. Equity | -899 074,92 | 1 664 950,21 | 50 000,00 | 1 516 457,21 | 1 462 809,37 |
| B. Liabilities and provisions for liabilities | 15 331 213,61 | 6 176 405,86 | 6 277 373,58 | 6 291 632,32 | 6 343 763,49 |
| I. Long-term liabilities | 0,00 | - | - | - | - |
| II. Short-term liabilities | 15 331 213,61 | 6 176 405,86 | 6 277 373,58 | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.